Lenvatinib: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors * Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma * Hypertension is a common side effect * Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation Category:Oncology Category:Medications" |
(No difference)
|
Latest revision as of 19:27, 17 September 2024
- Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors
- Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma
- Hypertension is a common side effect
- Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation
